文献速递产科母胎医学

遗传预测的体重指数与妊娠母体结局:一项两样本孟德尔随机化研究

Genetically predicted body mass index and maternal outcomes of pregnancy: A two-sample Mendelian randomisation study.
PubMed 文献 · BJOG · 2023-09-05

本研究采用两样本孟德尔随机化方法,利用434 794名女性的体重指数遗传工具变量及FINNGEN队列的结局数据,评估遗传预测的体重指数与妊娠母体结局的关联。结果显示,较高的遗传预测体重指数与子痫前期、妊娠期糖尿病和羊水过多的风险升高相关,与胎膜早破和产后抑郁的关联仅为提示性。

要点

  • 遗传预测BMI每升高1个标准差,子痫前期风险OR 1.68(95%CI 1.46-1.94)。
  • 遗传预测BMI每升高1个标准差,妊娠期糖尿病风险OR 1.67(95%CI 1.46-1.92)。
  • 遗传预测BMI每升高1个标准差,羊水过多风险OR 1.40(95%CI 1.00-1.96)。

核心结论

  • 较高的遗传预测体重指数与子痫前期、妊娠期糖尿病和羊水过多的风险显著升高相关。
  • 遗传预测体重指数与胎膜早破及产后抑郁的关系需在进一步研究中评估。
  • 本研究支持将体重指数作为妊娠母体发病率主要风险因素的干预目标。

研究设计与样本

  • 两样本孟德尔随机化研究,数据来自欧洲血统人群已发表的全基因组关联研究汇总统计。
  • 体重指数的工具变量来自一项纳入434 794名女性的研究。
  • 采用逆方差加权孟德尔随机化评估体重指数与所有结局的关联,并进行加权中位数和MR-Egger敏感性分析。
  • 女性特异性遗传关联估计值提取自FINNGEN队列第六轮分析数据。

主要发现

  • 较高的遗传预测体重指数与子痫前期风险升高相关(每标准差OR 1.68,95%CI 1.46-1.94,P=8.74×10^-13)。
  • 较高的遗传预测体重指数与妊娠期糖尿病风险升高相关(每标准差OR 1.67,95%CI 1.46-1.92,P=5.35×10^-14)。
  • 较高的遗传预测体重指数与羊水过多风险升高相关(每标准差OR 1.40,95%CI 1.00-1.96,P=0.049)。
  • 有证据提示遗传预测体重指数可能与胎膜早破风险升高相关(每标准差OR 1.16,95%CI 1.00-1.36,P=0.050)。
  • 有证据提示遗传预测体重指数可能与产后抑郁风险升高相关(每标准差OR 1.12,95%CI 0.99-1.27,P=0.062)。

临床怎么用

  • 作者认为,本研究支持将体重指数作为妊娠母体发病率主要风险因素的干预目标。
  • 作者指出,遗传预测体重指数与胎膜早破及产后抑郁的关系应在进一步研究中评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Observational studies have described associations between obesity and adverse outcomes of pregnancy but observational results are liable to influence by residual confounding. Mendelian randomisation (MR) leverages the 'natural' genetic randomisation to risk of an exposure occurring at allele assortment and conception. Similar to randomisation in a clinical trial, this limits the potential for the influence of confounding. DESIGN: A two-sample MR study. SETTING: Summary statistics from published genome wide association studies (GWAS) in European ancestry populations. POPULATION OR SAMPLE: Instrumental variants for body mass index (BMI) were obtained from a study on 434 794 females. METHODS: Inverse-variance weighted MR was used to assess the association between BMI and all outcomes. Sensitivity analyses with weighted median and MR-Egger were also performed. MAIN OUTCOME MEASURES: Female-specific genetic association estimates for outcomes were extracted from the sixth round of analysis of the FINNGEN cohort data. RESULTS: Higher genetically predicted BMI was associated with higher risk of pre-eclampsia (odds ratio [OR] per standard deviation 1.68, 95% confidence interval [CI] 1.46-1.94, P = 8.74 × 10-13 ), gestational diabetes (OR 1.67, 95% CI 1.46-1.92, P = 5.35 × 10-14 ), polyhydramnios (OR 1.40, 95% CI 1.00-1.96, P = 0.049). There was evidence suggestive of a potential association with higher risk of premature rupture of membranes (OR 1.16, 95% CI 1.00-1.36, P = 0.050) and postpartum depression (OR 1.12, 95% CI 0.99-1.27, P = 0.062). CONCLUSIONS: Higher genetically predicted BMI is associated with marked increase in risk of pre-eclampsia, gestational diabetes and polyhydramnios. The relation between genetically predicted BMI and premature rupture of membranes and postpartum depression should be assessed in further studies. Our study supports efforts to target BMI as a cardinal risk factor for maternal morbidity in pregnancy.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Ardissino M, Geddes-Barton M, Banerjee A, et al. Genetically predicted body mass index and maternal outcomes of pregnancy: A two-sample Mendelian randomisation study. BJOG. 2023. PMID: 37667670. doi:10.1111/1471-0528.17650

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。